Valuation: Phaarmasia Limited

Market Cap 513M 5.4M 4.68M 4.38M 4.01M 7.57M 7.68M 51.32M 20.13M 256M 20.26M 19.82M 856M P/E 2024
-38.3x
P/E 2025 -12.6x
Enterprise Value 511M 5.38M 4.67M 4.37M 4M 7.54M 7.65M 51.13M 20.05M 255M 20.19M 19.75M 852M EV / Sales 2024
0.64x
EV / Sales 2025 0.81x
Free-Float
-
Yield 2024 *
-
Yield 2025 -
1 day+2.09%
1 week-4.78%
Current month-4.14%
1 month-14.36%
3 months-13.43%
6 months-13.90%
Current year-24.62%
1 week 80.75
Extreme 80.75
89
1 month 80.75
Extreme 80.75
103.67
Current year 69
Extreme 69
131.75
1 year 26
Extreme 26
131.75
3 years 23.25
Extreme 23.25
131.75
5 years 20.2
Extreme 20.2
131.75
10 years 10.3
Extreme 10.3
131.75
Manager TitleAgeSince
Director of Finance/CFO - 11/02/2016
Compliance Officer - 02/01/2020
Director TitleAgeSince
Chairman 71 13/10/2010
Director/Board Member 55 08/12/2012
Director/Board Member 63 18/12/2012
Change 5-day change 1-year change 3-year change Capi.($)
+2.09%-4.78%+194.25%+244.19% 5.98M
+1.89%-1.49%+55.62%+165.18% 1,043B
-0.24%-3.22%+50.51%+52.02% 621B
-0.95%-7.38%+22.83%+65.08% 435B
0.00%+0.83%+42.80%+37.60% 361B
+0.58%-3.51%+31.12%+40.54% 293B
-1.55%-9.78%+5.61%+8.62% 251B
-0.73%+4.44%+34.91%+66.41% 220B
-0.24%-13.15%-4.02%-44.69% 201B
-0.68%-1.41%+16.36%+66.32% 164B
Average -0.13%-4.10%+45.00%+70.13% 358.91B
Weighted average by Cap. -0.24%-3.79%+37.57%+77.18%

Financials

2024 2025
Net sales 306M 3.22M 2.79M 2.61M 2.39M 4.51M 4.58M 30.58M 12M 153M 12.08M 11.81M 510M 244M 2.56M 2.22M 2.08M 1.91M 3.59M 3.64M 24.36M 9.56M 122M 9.62M 9.41M 406M
Net income -5.18M -54.48K -47.28K -44.26K -40.52K -76.38K -77.51K -518K -203K -2.59M -205K -200K -8.64M -15.89M -167K -145K -136K -124K -234K -238K -1.59M -623K -7.93M -627K -614K -26.49M
Net Debt -3.43M -36.08K -31.31K -29.31K -26.83K -50.59K -51.33K -343K -135K -1.71M -135K -133K -5.72M -1.94M -20.37K -17.67K -16.54K -15.15K -28.55K -28.97K -194K -75.95K -967K -76.46K -74.8K -3.23M
Logo Phaarmasia Limited
Phaarmasia Limited is an India-based company, which is primarily engaged in the manufacturing and sale of oral contraceptive pills (OCPs). The Company manufactures and markets oral contraceptive tablets with various therapeutic dosage combinations along with iron tablets for the Ministry of Health & Family Welfare and for exports. Its product categories include Hormone Products and Herbal Products. Its hormone products include Estradiol Valerate Tablets; Medroxyprogesterone Acetate Tablets; Cabergoline Tablets; Clomiphene Citrate Tablets; Levonorgestrel Tablet; Fluoxymesterone tablets; Liothyronine Sodium tablets; Oxandrolone tablets and others. Its herbal products include Smyle Herbal Toothpaste; Smyle Cough & Sore Throat Reliver and Smyle Mouth Ulcer Gel. Its injectables include Testosterone Cypionate Injection; Methenolone Enanthate Injection; Drostanolone, Testosterone and Trenbolone Inj, and Stanozolol Cypionate Inj.
Employees
36
Date Price Change Volume
06/08/26 ₹84.98 +2.09% 415
05/08/26 ₹83.24 -4.60% 146
04/08/26 ₹87.25 -0.51% 402
03/08/26 ₹87.70 -1.07% 193
31/07/26 ₹88.65 +4.29% 412
  1. Stock Market
  2. Stocks
  3. PHRMASI6 Stock